Taking one biopsy sample may not be enough to reveal a tumor’s genetic identity, according to a new study. The study analyzed the genetic variation among different regions of the same cancer tumor, using samples donated by patients with advanced kidney cancer.
A new study reveals that the lower health-related quality of life in younger women with breast cancer is linked to weight gain, increased psychological distress, less physical activity, and early onset of menopause, as well as infertility.
A new study has found that the number of women who have one or more additional surgeries to remove suspected residual tumor tissue (reexcisions) following breast-conserving surgery for breast cancer may vary widely. The rates of repeat surgery can vary by 1.7%–20.9% from doctor and hospital, according to the study.
The first drug for an advanced form of the most common type of skin cancer won approval from the U.S. Food and Drug Administration in January. The drug, Erivedge™ (vismodegib), was approved for adults with basal cell carcinoma that has spread to other locations in the body and who are unsuitable candidates for surgery or radiation ordinarily used to treat the disease.
Data from five large studies in China have reported that self-human papillomavirus testing, in which women collect samples of their own cervical-vaginal cells for DNA testing, is as sensitive as the standard Pap test used for cervical cancer screening.